Retinopathy of prematurity (ROP) remains a leading cause of morbidity in the very low-birth-weight (VLBW) infant. This study investigates a possible association between serum/blood glucose and the development of ROP.
INTRODUCTION
Retinopathy of prematurity (ROP) remains a leading cause of morbidity in the very low-birth-weight (VLBW) infant 1 in spite of the discovery of oxygen's involvement in its pathogenesis. 2 Numerous studies [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] have attempted to identify additional risk factors.
ROP's characteristic hallmark is neoproliferative growth of blood vessels in the retina. Another retinal condition with characteristic abnormal growth of new retinal vessels as the primary feature is diabetic retinopathy. The important role of hyperglycemia in the development of proliferative diabetic retinopathy has been studied extensively in adults. In diabetics, increased retinal blood flow and shear stresses, shown to occur with elevated serum glucose levels, 15, 16 have been implicated in proliferation and migration of endothelial cells. 17 Hyperglycemia (defined as plasma glucose values >150 mg/dl) is a common occurrence in the VLBW infant. In total, 45% of all infants less than 1000 g and 80% of those less than 750 g will develop hyperglycemia 18 with the risk of developing hyperglycemia being 18 times greater in infants weighing less than 1000 g than in those weighing more than 2000 g.
In spite of the frequent occurrence of hyperglycemia in the VLBW infant and the similarity between the neoproliferative blood vessel growth in ROP and diabetic retinopathy, no studies have been conducted that investigate the role of hyperglycemia in ROP. The purpose of this study was to evaluate a possible relation between glucose levels in VLBW infants and development of ROP.
METHODS

Study Population
A retrospective case -control chart (paper medical record) review of all infants born between 1992 and 1997 at the Johns Hopkins Hospital ( JHH) with birth weights (BW) less than 1000 g who developed Stage 3 or 4 ROP was conducted. Of 20 eligible neonates with ROP, four patients were excluded prior to data extraction because of incomplete charts; resulting in 16 patients. In two cases, the complete paper medical record could not be located (gestational age (GA) 29 and 25 3/7, ROP Stages 3 and 4, BW 776 and 908), and in two cases the charts were incomplete (GA 25 and 24 3/7, ROP Stage 4 for both, BW 880 and 885).
Controls were defined as VLBW infants who underwent the same routine serial eye exam as cases and were found to have either no eye disease or never progressed beyond Stage 1 ROP. Controls were matched 2:1 with ROP patients for GA, BW and year of birth. For one patient, we were unable to find more than one matching control.
Data collection
Initial ophthalmologic screening was performed on all patients (BW less than 1500 g or GA less than 29 weeks) at JHH through the Wilmer Eye Institute within 6 weeks of birth and follow-up was at the discretion of the ophthalmologist and neonatologist. Severity of ROP was staged by the International Classification of ROP 19 and infants were categorized by their most severe ROP examination. The GA was determined by the attending neonatologist's admission assessment based on history, fetal ultrasound and exam data. Glucose values consisted of both bedside whole blood glucoses (One-Touch, Lifescan Inc., USA) and laboratory serum glucoses. An average of five glucose measurements per day were used to calculate a daily maximum, minimum, median and average value for each individual patient. The same method was used to calculate daily maximum, minimum and average mean arterial pressures (MAP). These calculated data were subsequently used for statistical analysis. Glucose infusion rates as well as daily vitamin A and E supplementation were generated from all parenteral and oral sources.
Episodes of sepsis, presence of intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL) were recorded for the duration of each neonate's hospital course. Sepsis episodes were defined as any positive blood, urine (suprapubic or catheterized specimens) or cerebrospinal fluid culture for the duration of each neonate's hospital stay. IVH and PVL were graded by the attending radiologist using the most severe ultrasound results.
Antenatal steroid administration and patient demographics (birth weight, GA, year of birth, Apgar scores and gender) were extracted from the patient's medical records. Score for Neonatal Acute Physiology (SNAP) was generated for each patient as an index of illness severity. 20 Mean airway pressure (MawP) and inspired oxygen concentration (FiO 2 ) were recorded for days that patients were on mechanical ventilation or continuous positive airway pressure (CPAP).
For each patient, the following variables were recorded daily during the first month of life: FiO 2 , MawP, mean blood pressure averages (minimum and maximum), blood product transfusions, and all medications. In addition, all bedside whole blood and laboratory serum glucoses, as well as glucose supplementation (infusion and oral) rates were recorded for the first 31 days (birth to day of life 30). All infants received bedside glucose testing upon admission or if found to be clinically unstable. Frequency of testing was dependent upon prior glucose values (glucose <40 -q 1 to 2 hours, stable glucose >40 -q 4 to 8 hours).
Statistical Methods
The differences in means or proportions between cases and controls in above exposure variables were tested, using the Student t-test for continuous variables and w 2 test for categorical variables. We performed an analysis of the association between median glucose serum levels during the first 31 days of life and ROP. The measure of association and precision are estimated using conditional logistic regression models. As a result of a high multicollinearity among maximum, median, average and delta glucose values, we selected only the average glucose value for the analysis.
First, using a simple conditional logistic regression model, we calculated the odds ratio (OR) of ROP including one potential risk factor or confounder at a time. These risk factors included average serum glucose levels, average glucose infusion rate, average systolic, diastolic and mean arterial blood pressure (MAP), average mean airway pressure, average inspiratory oxygen concentration (FiO 2 ), GA, BW, average amount of vitamin E supplementation, presence of IVH Grade 3 or 4 and SNAP score. As a result of collinearity between systolic, diastolic and MAP as well as between vitamin E and vitamin A supplementation, we included only MAP and vitamin E into further models.
Second, a multiple conditional logistic regression model was chosen to reflect the study design with individual matching to reduce bias for the matching variables. We tested different models and decided to use a parsimonious model, including average serum glucose levels, average inspiratory oxygen concentration FiO 2 , BW and amount of vitamin E supplementation.
All statistical regression analyses were performed using Stata Statistical Software: Release 6.0 (StataCorp, College Station, TX, 1997) and reported p-values are two-sided with a ¼ 0.05. For other analysis, we used the statistical software package SPSS for Windows, Release 10.0 from SPSS, Inc.
RESULTS
A total of 16 charts of infants with ROP were analyzed. ROP patients were matched with 31 controls (Table 1) for GA (mean 25.0 weeks) and BW (mean 717 g), and year of birth (within 2 years).
A total of 7295 glucose values were collected on 47 patients. Of those, 5809 (80%) were bedside whole blood glucose readings, while the remaining 1486 measurements were laboratory serum glucose determinations. Average daily bedside and laboratory glucose values were closely correlated over the course of the hospitalization (Figure 1 ).
Perinatal Risk Factors
At the onset of the study period, the groups were not different ( Table 1) in markers of severity of illness as measured by SNAP score and Apgar scores at 1, 5 and 10 minutes. By design, BW ( p ¼ 0.16) and GA ( p ¼ 0.11) were matched between the two groups. There was no difference in gender, race or antenatal steroid administration. Glucose A significant difference was observed through comparison of the mean in most measures of glucose administration and testing ( Table 2 ). The patients in the ROP group had higher glucose maximums ( p ¼ 0.017), averages ( p ¼ 0.043) and medians ( p ¼ 0.048) for the first month of life (Figures 2 and 3 ). They also had more variability in daily glucose levels as measured by the difference between the daily maximum and minimum glucose (glucose delta) ( p ¼ 0.023) ( Figure 4 ). The higher glucose values among the ROP patients were present despite a lower glucose infusion rate ( p ¼ 0.04) administered to the ROP patients ( Figure 5 ). Analysis of the average serum glucose demonstrates that the ROP group not only had higher mean glucose values, but also displayed a glucose lability not seen in the control group ( Figure 6 ). These infants were also more likely to be placed on an insulin infusion to control their blood sugars (ROP 50%, control 16%, p ¼ 0.018). On more days than controls, ROP patients had at least one glucose value exceeding 150 mg/dl (ROP 8.4 days, controls 5.3 days, p ¼ 0.028). The ROP patients had a trend 21 of premature infants, a significant difference was noted between both groups in the first 3 days of life (mean glucose: ROP 103±42, control 89±36), while glucose values were not statistically different in days 4 to 7 ( Figure 7 ). Further, while ROP patients received significantly less glucose (ROP 4.8±2.2 mg/kg/minute, control 5.8±2.9 mg/kg/minute, p ¼ 0.015) than controls in the first 3 days, there was no difference in days 4 to 7. In the following 3 weeks, glucose values were again significantly higher in the ROP group despite the fact that these patients received less glucose through intravenous or other nutritional sources.
Clinical Features of Infants with ROP
Indicators of severity of illness were recorded for the 31-day study period (Table 3) . Both groups had a similar incidence of sepsis throughout their hospital course ( p ¼ 0.89). There were no differences in daily low, median or high MAPs between the groups. At days 7, 14, 21 and 28, there were no significant differences in the number of patients on intravenous pressors (dopamine/ dobutamine) or the number of patients receiving enteral feeds. There was no difference in the age at which infants regained their BW (Table 3) . During the first month of life, ROP infants required higher mean airway pressures (MawP) and inspired fraction of oxygen (FiO 2 ). ROP infants were also more likely to receive steroids in the first month of life ( Table 2 ). All patients in both groups received transfusions with packed red blood cells (PRBC) in the first month of life (Table 4) . ROP patients received more PRBC volume than controls ( p ¼ 0.01) and were more likely to have at least one platelet transfusion ( p<0.01). There was no significant difference in administration of fresh frozen plasma, plasmanate or albumin between the two groups (data not shown).
Patients with ROP were significantly more likely than the controls to be diagnosed with a Grade 3 or 4 IVH prior to discharge. There was no difference between the groups in the incidence of PVL (Table 3) . Table 4 lists medications where a difference in administration between the control and ROP group was noted in the first month of life. All infants received the diuretic Furosemide (Lasixt) during the first month of life, however, ROP patients received furosemide on significantly more days than controls (15 vs 8 days). More ROP patients received dopamine and famotidine during the study period, and control patients were more likely to receive theophylline. The ROP patients received less vitamins A and E during the first month of life (Table 4) .
Logistic Regression Analysis
Results from our simple and multiple logistic regression analysis are shown in Table 5 . A simple logistic regression analysis suggested an increased risk for the development of ROP for each 10 mg/dl increase of mean serum glucose (OR 1.96; 95% CI 1.13 to 3.42). An increase in mean FiO 2 also had an increased risk for the development of ROP (OR 1.06; 95% CI 1.004 to 1.13). A history of dopamine infusion (OR 5.4; 95% CI 1.16 to 25.2) or Grades 3 and 4 IVH (OR 7.3; 95% CI 1.53 to 34.7) also carried an increased risk.
Patients in this study were adequately matched for GA and BW; therefore, both parameters did not have a confounding effect in our model on the development of ROP.
We used a parsimonious multiple regression model that included BW, FiO 2 , Vitamin E and serum glucose. BW was included to account for potential sample bias, but fell out of the conditional logistic regression model as not significant. Other covariates were held constant and we forced oxygen exposure into 2, 22 and its restricted use, the incidence of ROP had decreased dramatically. 1 However, subsequently the number of infants identified with ROP has increased, apparently because of increased survival of VLBW infants rather than new iatrogenic factors. 23, 24 Researchers have concluded that supplemental oxygen, while a major risk factor for the development of ROP, is not the only cause of this disease 1 as demonstrated by a series of low-birth-weight infants who developed ROP without ever receiving supplemental oxygen. 25 Further, studies controlling arterial oxygen concentration precisely 26 did not lower the incidence of ROP, suggesting a multifactorial disease process. There has been extensive research into other etiologies of ROP, and many associated factors have been identified, including hypoxia, 3 hypercarbia, 4,5 hypocarbia, 6 prolonged hyperalimentation, 7 sepsis, 8 systemic candidiasis, 9 blood transfusions, 6, 8, 10 vitamin E deficiency, 12 steroid therapy 13 and IVH, 11 However, despite this research, there have been no new interventions that have resulted in further decline in the incidence of ROP. Retinopathy has also been associated with IVH and a common etiology based on the shared blood supply and impaired autoregulation of blood flow has been suggested. 11 The aim of this study was to determine whether elevated glucose levels are an independent risk factor for the development of ROP. The rational for researching this question was the known association of ROP with many diseases of the VLBW infant, including candidiasis, 9,14 sepsis, 8 IVH 11 and postnatal steroids. 13, 14 which in turn are frequently observed to be associated with hyperglycemia. 27, 28 Furthermore, adults with poorly controlled diabetes and associated hyperglycemia present a distinct neoproliferative retinopathy 29 model. Elevated glucose over a prolonged period of time has been the best-established concomitant factor associated with this diabetic complication. 30 In 1985, Perlman et al. 31 described the "absence of hypoglycemia" in 287 infants (BW <800 g) as a major risk factor for major impairments, especially blindness. In addition, glucose levels are known to be inversely correlated with Apgar scores, GA and BW, and directly correlated with inspired oxygen concentration and respiratory distress scores. 32 While the increase in the number of patients diagnosed with ROP in the 1970s was attributed largely to the improved survival of VLBW infants, this increase in ROP also coincided with more widespread use of parenteral glucose, 33, 34 further supporting a connection between glucose and ROP development. Despite these indirect links between elevated glucose levels and ROP, this study is the first attempt to evaluate a possible association between blood glucose measurements and hyperglycemia with the development of ROP in extremely lowbirth-weight infants.
Prior to the discussion of the results, a number of inherent study limitations must be argued:
1. Limited study period: ROP is a disease of developing retinal vessels characterized by excessive regrowth following an initial injury. The retina remains vulnerable to the development of ROP until complete vascularization occurs (usually by 40 to 44 weeks GA): however, it is particularly susceptible to injury in the initial newborn period. 35 We, therefore, limited this study of extremely premature infants to the first 31 days of life, when optimal regulation of environmental factors is crucial. 2. Retrospective design: Retrospective studies can demonstrate an association between variables, but rarely present convincing evidence of causation. This study's retrospective nature and relatively small patient number limit the conclusions that may be drawn from the results. The magnitude of the association between hyperglycemia and ROP would be better shown in a prospective study. Further, the inability to obtain complete records for four of the 20 eligible patients (20%) may have affected the study findings. 3. Serum and whole blood glucose: We relied heavily on the use of bedside glucose measurements. Bedside glucose determination based on whole blood is known to be hematocrit sensitive and will result in falsely low glucose values in infants with polycythemia. 36 The majority of glucose values documented in this study (80%) are based on bedside measurements and may have been falsely low, which in turn might have underestimated the incidence of true hyperglycemia in both groups. Furthermore, patients with abnormally high glucose values (revealed by the bedside testing) are more likely to receive confirmatory values from serum measurements especially given the diminished accuracy of bedside testing at the high-end of glucose values. This increased serum glucose measurement would occur more often in sick infants, potentially underestimating hypoglycemia in the controls. Although analysis of both bedside whole blood and laboratory serum glucose values independently resulted in significant differences in glucose values between the two study groups (Table 2) , we utilized only serum glucose values for the logistic regression analysis. 4. BW and GA have been identified as the most important risk factors for the development of ROP in the past. Therefore, we elected to match patients based on these parameters to avoid their confounding effect, and to focus on other factors, specifically glucose. It was not the intention of this study to further investigate the well-known effect of GA and BW. In addition, this study was not powered to determine interactions between maturity and glucose.
This study demonstrated a higher incidence of hyperglycemia among infants with ROP compared with GA and BW matched controls. ROP patients were found to have higher daily glucose measurements as expressed by daily average, median and maximum glucose. The actual clinical differences in mean daily glucose values among ROP patients and controls were small (approximately 10% difference), which might prompt questions regarding its clinical significance. However, the number of days with hyperglycemic events (glucose >150 mg/dl) was increased by almost 60% in the ROP group. Additionally, the glucose tolerance among the ROP infants was found to be decreased as measured by the lower rate of glucose supplementation and higher frequency of insulin infusions. In a multiple logistic regression analysis, an increase of the mean daily glucose concentration by only 10 mg/dl increased the likelihood of developing ROP by 170%.
Increased retinal blood flow has been associated with increasing severity of retinopathy in diabetics. 37 Hyperglycemia has been demonstrated in adults to result in increased retinal blood flow and oxygen consumption. 38 In infants, the use of dexamethasone (20% of patients developed significant hyperglycemia) was associated with increased cerebral and ocular blood flow velocities. 39 Recently, vascular endothelial growth factor (VEGF) has been identified as a major contributing factor in ROP and other proliferative retinopathies. 40 VEGF expression is temporally and spatially associated with the onset of ischemia-induced intraocular neovascularization in several animal models. [40] [41] [42] [43] VEGF may represent the pathophysiologic link between elevated glucose levels and ROP: Brooks et al. 44 found that under hypoxic conditions, increasing glucose concentration amplified expression of VEGF protein in rat retinal Muller cells. This upregulation of VEGF at the mRNA and protein levels 45 has also been found in rat mesangial cells exposed to high glucose. A recent study linked low levels of insulin-like growth factor I occurring after birth in the premature infant with accumulation of VEGF in the retina and the development of ROP. 46 This study corroborated the well-established association of oxygen and retinopathy with ROP infants requiring higher delivered mean airway pressures and inspired oxygen. Antenatal steroids, which have been shown to decrease the risk of ROP Stage 2 or higher, 47 were administered to both groups equally and thus should not have played a role in our population. Postnatal steroids, however, were administered more frequently in the ROP group. The more frequent use of postnatal steroids could be interpreted as a measure of severity of illness, but might also have contributed to the higher incidence of hyperglycemia in the ROP group.
Providing prophylactic supplements of vitamin E to reduce the incidence or the severity of ROP remains controversial, 48 especially given the reports of an increased incidence of necrotizing enterocolitis 49, 50 and sepsis 50 54 have been well-documented risk factors for development of ROP. A more recent study 55 did not find a significant risk for ROP with more frequent blood transfusions: however, infants were not enrolled until they were 4 weeks old supporting the conclusion that the immediate postnatal period is critical for ROP development. We confirmed the association of ROP with PRBC transfusion volume given in the first month of life. Platelet administration was also found to be a significant risk factor.
CONCLUSION
In the past, ROP has been extensively studied in a number of case-control studies examining multiple risk factors. Matching ROP patients and controls to eliminate the effect of prematurity and BW, several risk factors for the development of ROP remained. These include the prolonged use of oxygen and indicators of severity of illness such as blood transfusions, frequency of blood gas measurements or abnormal results on these measurements, ventilator days, and apnea and bradycardia requiring intervention. 35 This study examined the association of glucose levels and frequency of hyperglycemic events with the development of ROP. After adjusting for oxygen exposure during the first month of life, the data suggest an association between high glucose levels and the occurrence of ROP. Vitamin E might have a protective effect.
The obvious question remains: is hyperglycemia pathophysiologically linked to ROP, or does hyperglycemia represent another marker of severity of illness such as the number of blood transfusions or the incidence of sepsis? This study was not designed to answer this question. However, it is important to note, that while both groups were not different in risk factors and initial measures of illness, the ROP group was found to have some markers indicating a more severe course during the first month of life. These markers included number of transfusions, need for diuretic administration, frequency of platelet transfusion, use of postnatal steroids, slower advancement on hyperalimentation and enteral feeding (as expressed by vitamin A and E supplementation), prolonged dopamine infusions and more hypotensive episodes. Nevertheless, emerging basic science evidence implicates abnormal VEGF levels and increased retinal blood flow in response to hyperglycemia as a potential cause for the development of ROP.
Hyperglycemia in the neonate has been recognized as a serious problem resulting in osmotic diuresis, dehydration, weight loss with increased mortality and increased incidence for IVH. 56 Further prospective studies will determine if ROP must be added to this list of complications.
